Rights and permissions
About this article
Cite this article
Allison, M. Clinical setbacks reduce IGF-1 inhibitors to cocktail mixers. Nat Biotechnol 30, 906–907 (2012). https://doi.org/10.1038/nbt1012-906c
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1012-906c
- Springer Nature America, Inc.
This article is cited by
-
Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer
Scientific Reports (2020)
-
Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?
Drug Safety (2017)